Different point mutations in the met oncogene elicit distinct biological properties
- 1 February 2000
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 14 (2) , 399-406
- https://doi.org/10.1096/fasebj.14.2.399
Abstract
The MET proto-oncogene, encoding the tyrosine kinase receptor for HGF, controls genetic programs leading to cell growth, invasiveness, and protection from apoptosis. Recently, MET mutations have be...Keywords
This publication has 35 references indexed in Scilit:
- Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasisOncogene, 1999
- Phosphoinositide 3-Kinase Induces Scattering and Tubulogenesis in Epithelial Cells through a Novel PathwayJournal of Biological Chemistry, 1998
- Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesisNature, 1996
- Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.Journal of Clinical Investigation, 1996
- Motogenic and morphogenic activity of epithelial receptor tyrosine kinases.The Journal of cell biology, 1996
- Pathways Downstream of Shc and Grb2 Are Required for Cell Transformation by the Tpr-Met OncoproteinJournal of Biological Chemistry, 1996
- The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro.Molecular Biology of the Cell, 1996
- Disruption of epithelial cell-matrix interactions induces apoptosisThe Journal of cell biology, 1994
- Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factorPublished by Elsevier ,1991
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991